Literature DB >> 28619676

Peroxynitrite-modified histone as a pathophysiological biomarker in autoimmune diseases.

Md Asad Khan1, Khursheed Alam2, Md Zafaryab3, M Moshahid A Rizvi3.   

Abstract

Under physiological conditions, reactive nitrogen and oxygen species are produced continuously. However, excess of these radicals may damage biomolecules like lipids, proteins and nucleic acids. These reactive species have been implicated in many disease conditions including acute/chronic inflammation, rheumatoid arthritis (RA), neurodegenerative diseases and systemic lupus erythematosus (SLE). Peroxynitrite, an oxidant and nitrating molecule, formed in in vivo, when nitric oxide reacts with superoxide radical. The abnormal levels of nitrotyrosine detected in tissues affected by autoimmune diseases have been attributed to peroxynitrite-mediated enhanced nitration of tyrosine residues in proteins. The chromosomal histone proteins are conserved and weak immunogens. However, they exhibit strong immunogenicity after nitration. Rabbits challenged with peroxynitrite-modified histone induce high titre antibodies, indicating that peroxynitrite modification generated immunogenic epitopes. The preferential binding of peroxynitrite-modified histones by autoantibodies derived from SLE and RA sera shows oxidatively and nitrated modified histones involve in the initiation and progression of autoimmune diseases. This review article presents the literature review of the physicochemical and immunological studies on histone proteins modified with peroxynitrite with an objective of the possible role of oxidatively nitrated histones in the initiation/progression of autoimmune inflammatory diseases.
Copyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  3- Nitrotyrosine; Autoimmune diseases; Autoimmunity; Histones; Peroxynitrite

Mesh:

Substances:

Year:  2017        PMID: 28619676     DOI: 10.1016/j.biochi.2017.06.006

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.

Authors:  Xiaofang Li; Run Tian; Hugh Gao; Yongkang Yang; Bryan R G Williams; Michael P Gantier; Nigel A J McMillan; Dakang Xu; Yiqun Hu; Yan'e Gao
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

Review 2.  Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Hsien-Tzung Liao; Ko-Jen Li; Hui-Ting Lee; Cheng-Shiun Lu; Cheng-Han Wu; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

Review 3.  Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis.

Authors:  Océane Perdaens; Vincent van Pesch
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

4.  Assessment of a combination of plasma anti-histone autoantibodies and PLA2/PE ratio as potential biomarkers to clinically predict autism spectrum disorders.

Authors:  Afaf El-Ansary; Mona Al-Onazi; Abdulrahman M Alhowikan; Mashael A Alghamdi; Laila Al-Ayadhi
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

Review 5.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

Review 6.  Pillars and Gaps of S-Nitrosylation-Dependent Epigenetic Regulation in Physiology and Cancer.

Authors:  Luisa Salvatori; Francesco Spallotta; Carlo Gaetano; Barbara Illi
Journal:  Life (Basel)       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.